Results 131 to 140 of about 6,763 (184)

Antioxidant Effects of Carnosine-Enriched Chicken Meat Consumption in Athletes: Modulation of SOD Activity and Superoxide Levels-A Randomized Control Trial. [PDF]

open access: yesAntioxidants (Basel)
Kolobarić N   +7 more
europepmc   +1 more source

Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis. [PDF]

open access: yesMol Med Rep
Gao J   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Carnosine and Carnosine-Related Antioxidants: A Review

Current Medicinal Chemistry, 2005
First isolated and characterized in 1900 by Gulewitsch, carnosine ( β-alanyl-L-hystidine) is a dipeptide commonly present in mammalian tissue, and in particular in skeletal muscle cells; it is responsible for a variety of activities related to the detoxification of the body from free radical species and the by-products of membrane lipids ...
Andrea Guiotto   +3 more
openaire   +4 more sources

Physiology and Pathophysiology of Carnosine

Physiological Reviews, 2013
Carnosine (β-alanyl-l-histidine) was discovered in 1900 as an abundant non-protein nitrogen-containing compound of meat. The dipeptide is not only found in skeletal muscle, but also in other excitable tissues. Most animals, except humans, also possess a methylated variant of carnosine, either anserine or ophidine/balenine, collectively called the ...
A. A. Boldyrev, G. Aldini, W. Derave
openaire   +2 more sources

Carnosine and Lung Disease

Current Medicinal Chemistry, 2020
Carnosine (β-alanyl-L-histidine) is a small dipeptide with numerous activities, including antioxidant effects, metal ion chelation, proton buffering capacity, and inhibitory effects on protein carbonylation and glycation. Carnosine has been mostly studied in organs where it is abundant, including skeletal muscle, cerebral cortex, kidney, spleen, and ...
Ken-Ichiro, Tanaka, Masahiro, Kawahara
openaire   +2 more sources

Carnosine and Diabetic Nephropathy

Current Medicinal Chemistry, 2020
Diabetic Nephropathy (DN) is a major complication in patients with type 1 or type 2 diabetes and represents the leading cause of end-stage renal disease. Novel therapeutic approaches are warranted. In view of a polymorphism in the carnosinase 1 gene CNDP1, resulting in reduced carnosine degradation activity and a significant DN risk reduction ...
Verena, Peters   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy